Sepsis

Medical Disclaimer: This information is intended for educational purposes only and should not be considered medical advice. It is not a substitute for professional medical judgment, diagnosis, or treatment. Clinicians must always use their professional judgment and consider individual patient circumstances when making healthcare decisions. Guidelines and evidence evolve; users should consult the latest official guidelines and primary literature.

---

Overview

• Definition: Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. It is not merely an infection but an aberrant and harmful immune response that damages the body's own tissues and organs. Septic shock is a subset of sepsis in which particularly profound circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than with sepsis alone. Clinically, patients with septic shock can be identified by a need for vasopressor therapy to maintain a mean arterial pressure (MAP) $\ge$ 65 mmHg and having a serum lactate level > 2 mmol/L (> 18 mg/dL) despite adequate fluid resuscitation.
• Epidemiology: Sepsis is a major global health challenge.
  • Incidence: Estimated at 49 million cases globally per year, with increasing incidence in many regions.
  • Mortality: Global mortality approaches 11 million deaths annually, accounting for approximately 1 in 5 deaths worldwide. In high-income countries, hospital mortality ranges from 10-30% for sepsis and 30-50% for septic shock.
  • Demographics: Affects all age groups, but incidence and mortality are highest in the very young (neonates, infants), the elderly, and individuals with chronic comorbidities or immunosuppression.
• Classification:
  • Sepsis: Life-threatening organ dysfunction (acute change in total SOFA score $\ge$ 2 points consequent to the infection).
  • Septic Shock: Sepsis with persistent hypotension requiring vasopressors to maintain MAP $\ge$ 65 mmHg AND serum lactate > 2 mmol/L (18 mg/dL) despite adequate fluid resuscitation.
  • Source of Infection: Classified by the primary site of infection (e.g., pneumonia, urinary tract infection, intra-abdominal infection, skin/soft tissue infection).

Pathophysiology

• Mechanism: Sepsis involves a complex, dysregulated host response to infection.
  • Initial Insult: Pathogen-associated molecular patterns (PAMPs) from microorganisms and danger-associated molecular patterns (DAMPs) from damaged host cells trigger an innate immune response.
  • Dysregulated Response: Instead of a localized, protective response, sepsis results in a widespread, uncontrolled inflammatory cascade. This involves both pro-inflammatory (e.g., TNF- $\alpha$, IL-1, IL-6) and anti-inflammatory (e.g., IL-10, TGF- $\beta$) mediators, leading to a state of immune dysregulation.
  • Endothelial Dysfunction: Widespread endothelial activation and injury lead to increased vascular permeability, vasodilation, microvascular thrombosis, and impaired tissue oxygenation.
  • Mitochondrial Dysfunction: Cellular energy production is impaired, contributing to organ dysfunction.
  • Coagulopathy: Activation of coagulation pathways and inhibition of fibrinolysis contribute to microthrombi formation and disseminated intravascular coagulation (DIC).
  • Organ Dysfunction: The combination of hypoperfusion, direct cellular injury, mitochondrial dysfunction, and microvascular abnormalities leads to progressive dysfunction of multiple organ systems (e.g., acute kidney injury, acute respiratory distress syndrome, liver dysfunction, cardiac dysfunction, central nervous system dysfunction).
• Risk Factors:
  • Age: Extremes of age (neonates/infants and elderly >65 years).
  • Immunosuppression: HIV/AIDS, cancer (especially chemotherapy), organ transplantation, chronic corticosteroid use, primary immunodeficiency.
  • Chronic Medical Conditions: Diabetes mellitus, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease (COPD), heart failure, obesity.
  • Recent Hospitalization/Surgery/Trauma: Exposure to healthcare-associated infections, invasive procedures, open wounds.
  • Indwelling Devices: Central venous catheters, urinary catheters, mechanical ventilation, endotracheal tubes.
  • Genetic Predisposition: Certain genetic polymorphisms may increase susceptibility.
  • Prior Sepsis Episode: Increased risk of recurrence and long-term complications.
• Protective Factors:
  • Vaccination: Immunization against common pathogens (e.g., influenza, pneumococcus).
  • Infection Prevention & Control: Hand hygiene, aseptic technique, timely removal of unnecessary catheters/invasive devices.
  • Early Recognition and Treatment: Prompt identification of infection and initiation of appropriate therapy prevents progression to sepsis.
  • Good Baseline Health: Absence of chronic comorbidities.
  • Nutritional Status: Adequate nutrition supports immune function.

Clinical Presentation

Signs and Symptoms

Sepsis is a syndrome, not a specific disease, and its presentation can be highly variable, often mimicking other conditions. Suspicion should be high in any patient with a suspected infection and new or worsening organ dysfunction.

• Cardinal Features: Often subtle in early stages, becoming more pronounced as organ dysfunction progresses.
  • General: Altered mental status (confusion, disorientation, lethargy), fever (>38.3°C or 100.9°F) or hypothermia (<36°C or 96.8°F), chills, malaise.
  • Cardiovascular: Tachycardia (heart rate >90 bpm), hypotension (systolic BP <100 mmHg or MAP <65 mmHg, or drop in SBP >40 mmHg from baseline), capillary refill time >2 seconds.
  • Respiratory: Tachypnea (respiratory rate >22 breaths/min), dyspnea, hypoxemia.
  • Renal: Oliguria (<0.5 mL/kg/hr for >2 hours).
  • Hematologic: Petechiae, purpura, signs of bleeding or thrombosis.
  • Skin: Warm, flushed skin (early, distributive shock) or cool, clammy, mottled skin (late, hypoperfusion).
• Early Signs (qSOFA criteria): A quick, bedside screening tool for patients with suspected infection. A score of $\ge$ 2 suggests higher risk of poor outcome.
  • Respiratory rate $\ge$ 22/min
  • Altered mental status (Glasgow Coma Scale <15)
  • Systolic blood pressure $\le$ 100 mmHg
• Advanced Signs (Signs of Organ Dysfunction):
  • Respiratory: Severe dyspnea, accessory muscle use, cyanosis, crackles (ARDS).
  • Cardiovascular: Cold extremities, absent peripheral pulses, severe hypotension refractory to fluids, arrhythmias.
  • Neurological: Somnolence, stupor, coma, focal neurological deficits.
  • Renal: Anuria, signs of fluid overload (edema).
  • Hepatic: Jaundice, coagulopathy.
  • Gastrointestinal: Ileus, abdominal distension, GI bleeding.
  • Hematologic: DIC (bleeding from multiple sites, widespread purpura, thrombosis).
• Atypical Presentations:
  • Elderly: May present with only altered mental status, generalized weakness, or malaise without fever. Hypothermia is common.
  • Immunocompromised: May have blunted inflammatory responses, leading to absent fever or leukocytosis despite severe infection.
  • Patients on Beta-blockers: May not exhibit expected tachycardia.
  • Children: Can present with lethargy, poor feeding, decreased activity, or specific pediatric sepsis criteria (e.g., prolonged capillary refill, weak pulses).

Physical Examination

A thorough head-to-toe examination is crucial to identify signs of organ dysfunction and potential sources of infection.

• Inspection:
  • General: Level of consciousness (alert, confused, lethargic, obtunded), signs of distress (tachypnea, accessory muscle use, grunting in children), overall appearance (cachexia, dehydration).
  • Skin: Color (pallor, cyanosis, mottling, jaundice), turgor, presence of rash (petechial, purpuric), cellulitis, wound infection, necrotic areas, central line sites for erythema/drainage.
  • Mucous Membranes: Dryness (dehydration), cyanosis.
  • Respiratory: Respiratory rate, depth, symmetry of chest wall movement, use of accessory muscles, nasal flaring.
  • Cardiovascular: Jugular venous distension, peripheral edema.
  • Abdomen: Distension, surgical scars, ostomies.
• Palpation:
  • Skin: Temperature (warm/flushed or cool/clammy), turgor.
  • Cardiovascular: Peripheral pulses (rate, rhythm, quality – bounding or thready), capillary refill time (press nail bed for 5 seconds, normal <2 seconds).
  • Abdomen: Tenderness, guarding, rebound, masses, organomegaly.
  • Extremities: Edema, warmth, tenderness.
• Special Tests:
  • Neurological Exam: GCS score, pupillary response, focal deficits, meningeal signs (nuchal rigidity) if CNS infection suspected.
  • Respiratory Exam: Auscultation for abnormal breath sounds (crackles, rhonchi, wheezes), decreased breath sounds.
  • Cardiac Exam: Auscultation for murmurs, gallops, rubs, heart sounds (S3, S4).
  • Source-specific Exams: Careful examination of indwelling catheters, wounds, surgical sites, perianal area, joints.

Diagnostic Approach

Timely and accurate diagnosis is paramount for effective sepsis management. The approach is guided by the suspicion of infection and organ dysfunction.

History Taking

• Key Questions:
  • Infection Source: Location of pain, cough (sputum?), dysuria (flank pain?), diarrhea, abdominal pain, skin lesions, new rashes, headache, neck stiffness.
  • Recent Events: Recent illness, surgery, trauma, hospitalization, invasive procedures, antibiotic use, travel, animal exposure, illicit drug use.
  • Symptoms Timeline: Onset and progression of fever, chills, altered mental status, hypotension, oliguria, dyspnea.
  • Comorbidities: Diabetes, heart disease, lung disease, kidney disease, liver disease, immunosuppression (HIV, cancer, organ transplant, corticosteroids).
  • Medications: Immunosuppressants, anticoagulants, recent antibiotics.
  • Allergies: Especially to antibiotics.
  • Vaccination Status: Especially for pneumococcus, influenza.
• Red Flags:
  • Acute, unexplained change in mental status.
  • New-onset hypotension or significant drop from baseline blood pressure.
  • Signs of acute organ dysfunction (e.g., severe dyspnea, anuria, jaundice, mottled skin, non-blanching rash).
  • Clinical suspicion of a high-risk source of infection (e.g., necrotizing fasciitis, meningitis, toxic shock syndrome).
  • Unexplained metabolic acidosis (elevated lactate).

Laboratory Tests

Rapid collection of appropriate labs is critical, often before antibiotic administration.

• First-Line:
  • Complete Blood Count (CBC) with differential: Leukocytosis (>12,000/µL), leukopenia (<4,000/µL), bandemia (absolute band count >10% or >1,500/µL), thrombocytopenia (<100,000/µL).
  • Metabolic Panel (CMP/BMP): Electrolytes, creatinine (for AKI), blood urea nitrogen (BUN), glucose (hyper/hypoglycemia), liver function tests (bilirubin, ALT, AST, alkaline phosphatase).
  • Lactate: Serum lactate level (initial and serial measurements). A level >2 mmol/L is significant; >4 mmol/L indicates severe hypoperfusion.
  • Blood Cultures: At least two sets (aerobic and anaerobic bottles) from different sites, before administering antibiotics if possible, but do not delay antibiotics if cultures cause significant delay (>45 min).
  • Procalcitonin (PCT): Can be used to support diagnosis of bacterial infection and guide antibiotic de-escalation/discontinuation. Levels >0.5 ng/mL suggest bacterial infection, with higher levels indicating increased severity.
  • C-reactive Protein (CRP): Non-specific inflammatory marker. Levels >10 mg/L are common in infection.
  • Arterial Blood Gas (ABG) or Venous Blood Gas (VBG): To assess acid-base status, oxygenation, and ventilation.
  • Coagulation Panel: Prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (aPTT), D-dimer (often elevated in sepsis, especially if DIC).
  • Urinalysis with culture: If UTI suspected.
  • Other cultures: Sputum, wound, catheter tip, CSF (if meningitis/encephalitis suspected), fluid from sterile sites (pleural, peritoneal, joint) based on suspected source.
• Confirmatory:
  • Positive Cultures: Isolation of a pathogenic microorganism from blood or other normally sterile sites. Note: cultures can be negative in up to 50% of sepsis cases.
  • Rising Biomarkers: Persistently elevated or rising lactate, procalcitonin, CRP.
• Monitoring:
  • Serial Lactate: To assess response to resuscitation (lactate clearance). Aim for $\ge$ 20% decrease every 2 hours.
  • Renal Function: Daily creatinine, BUN, urine output.
  • Liver Function: Daily AST, ALT, bilirubin.
  • Coagulation Parameters: Daily PT/INR, aPTT, platelet count.
  • Inflammatory Markers: Serial CRP, procalcitonin (to guide antibiotic duration).
  • Vital Signs: Continuous monitoring (HR, BP, RR, SpO2, temp).

Imaging

Imaging studies are essential to identify or confirm the source of infection and assess organ damage.

• Recommended:
  • Chest X-ray (CXR): For suspected pulmonary source (pneumonia, ARDS).
  • Abdominal Ultrasound (US) or Computed Tomography (CT): For suspected intra-abdominal infection (appendicitis, cholecystitis, diverticulitis, abscess). CT with IV contrast is generally preferred for detailed visualization.
  • Urinary Tract Ultrasound/CT: If urinary obstruction or abscess suspected.
  • CT Head: If neurological changes suggest CNS infection, stroke, or mass lesion.
• Advanced:
  • Echocardiography (ECHO): Transthoracic (TTE) or transesophageal (TEE) for suspected endocarditis, valvular dysfunction, or to assess cardiac function and fluid responsiveness in shock.
  • Magnetic Resonance Imaging (MRI): For more detailed assessment of CNS, musculoskeletal, or soft tissue infections, especially if CT is inconclusive or contraindicated.
  • Interventional Radiology (IR) procedures: For drainage of abscesses or collection.

Management

Sepsis management is a time-sensitive medical emergency requiring rapid recognition and implementation of the "Sepsis Bundles." Adherence to the Surviving Sepsis Campaign (SSC) guidelines is critical.

Acute Management (The "Hour-1 Bundle")

The SSC 2021 guidelines emphasize completing key interventions within 1 hour of recognition of sepsis/septic shock.

• Immediate (Within 1 hour):
  1. Measure lactate level: And remeasure if initial lactate is >2 mmol/L.
  2. Obtain blood cultures: At least two sets (aerobic and anaerobic) before administering antibiotics. Do not delay antibiotic administration if cultures cause significant delay.
  3. Administer broad-spectrum antibiotics: Start broad-spectrum intravenous antibiotics immediately, preferably within 1 hour of recognition of sepsis or septic shock. The choice should cover likely pathogens based on suspected source, local epidemiology, and patient risk factors.
  4. Administer crystalloid fluid: For hypotension or lactate $\ge$ 4 mmol/L, administer 30 mL/kg of intravenous crystalloid solution over 3 hours (initial bolus often given more rapidly). Balanced crystalloids (e.g., Lactated Ringer's) are preferred over normal saline.
  5. Apply vasopressors: If the patient is hypotensive during or after fluid resuscitation to maintain a Mean Arterial Pressure (MAP) $\ge$ 65 mmHg.
• Stabilization (Early Management Priorities):
  • Source Control: Timely diagnosis and intervention to control the source of infection (e.g., drainage of abscess, debridement of infected tissue, removal of infected catheters, surgical repair of perforated viscus). This should be performed as soon as medically and surgically feasible after initial resuscitation.
  • Respiratory Support:
    • Oxygen administration to maintain SpO2 $\ge$ 92-96%.
    • Mechanical ventilation for ARDS or respiratory failure. Use low tidal volume ventilation (6 mL/kg predicted body weight) and limiting plateau pressures (<30 cm H2O).
  • Hemodynamic Monitoring: Invasive arterial pressure monitoring recommended for patients on vasopressors. Central venous catheter for CVP and ScvO2 monitoring may be considered, but current evidence emphasizes dynamic measures of fluid responsiveness (e.g., passive leg raise, stroke volume variation) over static measures.
  • Glycemic Control: Maintain blood glucose levels <180 mg/dL (10 mmol/L) with insulin infusion, avoiding hypoglycemia.
  • Stress Ulcer Prophylaxis: With proton pump inhibitors (PPIs) or H2 receptor blockers in patients with risk factors for GI bleeding (e.g., mechanical ventilation, coagulopathy).
  • Venous Thromboembolism (VTE) Prophylaxis: With unfractionated heparin (UFH) or low molecular weight heparin (LMWH) in patients without contraindications. Mechanical prophylaxis (intermittent pneumatic compression devices) should be used if pharmacologic prophylaxis is contraindicated.
• Emergency (Crisis Management):
  • Airway Management: Rapid sequence intubation for patients with impending respiratory failure, severe hypoxemia, or altered mental status with inadequate airway protection.
  • Central Venous Access: For reliable delivery of vasopressors and potentially for advanced hemodynamic monitoring.
  • Cardiopulmonary Resuscitation: If cardiac arrest occurs.

Chronic Management (Post-ICU/Sepsis Syndrome)

Management shifts to supportive care, rehabilitation, and prevention of long-term complications once acute shock has resolved.

• Pharmacological:
  • Antibiotic De-escalation: Once culture results and sensitivities are available, narrow the antibiotic spectrum. Duration is typically 7-10 days for most infections; shorter courses (e.g., 3-5 days for uncomplicated UTIs) or longer courses for specific infections (e.g., endocarditis, osteomyelitis, neutropenic sepsis). Procalcitonin can guide discontinuation.
  • Vasopressor Weaning: Gradual titration downwards as hemodynamic stability improves.
  • Corticosteroids: Low-dose corticosteroids (e.g., hydrocortisone 200 mg/day IV in divided doses or continuous infusion) are recommended for septic shock refractory to fluid and vasopressor therapy.
  • Other Supportive Medications: Analgesia, sedation (minimize where possible), diuretics for fluid overload, medications for chronic comorbidities.
• Non-pharmacological:
  • Rehabilitation: Early mobilization and physical therapy to prevent critical illness polyneuropathy/myopathy and aid recovery from muscle weakness. Occupational therapy for activities of daily living.
  • Nutritional Support: Early enteral nutrition (within 48 hours) is preferred over parenteral nutrition in critically ill patients.
  • Psychosocial Support: For anxiety, depression, PTSD, and cognitive impairment associated with post-sepsis syndrome.
• Monitoring:
  • Organ Function Recovery: Serial monitoring of renal, hepatic, cardiac, and respiratory function.
  • Infection Surveillance: For superinfections or recurrent infections.
  • Post-Sepsis Syndrome Assessment: Regular follow-up for cognitive, physical, and psychological impairments.

Treatment Algorithms

The management algorithm primarily follows the SSC "Hour-1 Bundle."

• First-Line:
  1. Early Recognition: Use qSOFA or other validated screening tools in suspected infection.
  2. Resuscitation:
     • Initial Lactate measurement.
     • Blood cultures (2 sets) before antibiotics.
     • Broad-spectrum IV antibiotics within 1 hour.
     • IV crystalloids 30 mL/kg for hypotension or lactate $\ge$ 4 mmol/L.
     • Vasopressors (Norepinephrine first-line) if MAP <65 mmHg despite fluids.
  3. Source Control: Timely intervention (e.g., drainage, debridement).
• Second-Line (Adjunctive Therapies):
  • Vasopressors: If norepinephrine is insufficient, add vasopressin (up to 0.03 units/min) or epinephrine. Dopamine is generally not recommended as a first-line agent. Phenylephrine is an option if other vasopressors are causing tachyarrhythmias.
  • Corticosteroids: Hydrocortisone 200 mg/day (e.g., 50 mg IV q6h or continuous infusion) for refractory septic shock.
  • Blood Products: Transfusion of red blood cells (RBCs) when hemoglobin falls below 7 g/dL (unless active bleeding, coronary ischemia, or severe hypoxemia). Platelet transfusion for counts <10,000/µL or <20,000/µL with significant bleeding risk, or <50,000/µL with active bleeding/surgery/invasive procedures.
  • Renal Replacement Therapy (RRT): For acute kidney injury with severe metabolic derangements (refractory hyperkalemia, severe acidosis, fluid overload).
• Refractory Cases:
  • Mechanical Circulatory Support: Consider ECMO (extracorporeal membrane oxygenation) for severe ARDS or refractory cardiogenic shock, though evidence is limited in sepsis.
  • Advanced Hemodynamic Monitoring: Beyond basic arterial line, consider pulmonary artery catheter or advanced cardiac output monitoring (e.g., transthoracic echocardiography, transpulmonary thermodilution) to guide fluid and vasopressor therapy.
  • Investigational Therapies: Some studies investigate therapies like high-dose vitamin C, thiamine, and hydrocortisone, but current evidence does not support routine use. Other modalities like polymyxin B hemoperfusion are highly controversial.

Complications

Sepsis can lead to widespread and severe organ damage.

• Common:
  • Acute Kidney Injury (AKI): Most common organ dysfunction.
  • Acute Respiratory Distress Syndrome (ARDS): Severe lung injury requiring mechanical ventilation.
  • Disseminated Intravascular Coagulation (DIC): Simultaneous bleeding and clotting.
  • Critical Illness Polyneuropathy/Myopathy (CIP/CIM): Weakness, difficulty weaning from ventilation.
  • Cardiac Dysfunction: Sepsis-induced cardiomyopathy.
• Serious:
  • Multiple Organ Dysfunction Syndrome (MODS): Failure of two or more organ systems.
  • Refractory Septic Shock: Persistent hypotension despite adequate fluid and vasopressor support.
  • Stroke, Myocardial Infarction: Due to procoagulant state or hypoperfusion.
  • Gangrene/Limb Ischemia: Due to microvascular thrombosis, especially in severe shock.
• Long-term (Post-Sepsis Syndrome):
  • Cognitive Impairment: New or worsened cognitive deficits, including memory problems, difficulty concentrating, and executive dysfunction.
  • Physical Debility: Persistent weakness, fatigue, muscle wasting, reduced exercise capacity, chronic pain.
  • Psychological Distress: Post-traumatic stress disorder (PTSD), anxiety, depression.
  • Increased Risk of Recurrent Infections: And readmissions.
  • Chronic Organ Dysfunction: Persistent renal insufficiency, pulmonary fibrosis, cardiac dysfunction.

Prognosis

Prognosis is highly variable and depends on multiple factors.

• Factors Affecting Outcome:
  • Severity of Illness: Higher SOFA score, presence of septic shock, and number of organ failures correlate with worse prognosis.
  • Age: Extremes of age are associated with higher mortality.
  • Comorbidities: Pre-existing chronic diseases (e.g., heart failure, chronic kidney disease, malignancy, immunosuppression).
  • Source of Infection: Some sources (e.g., pneumonia, peritonitis, necrotizing fasciitis) carry higher mortality rates.
  • Pathogen: Virulence of the infecting microorganism and presence of antibiotic resistance.
  • Timeliness of Intervention: Delay in antibiotic administration and fluid resuscitation is strongly associated with increased mortality.
  • Adequacy of Source Control: Failure to control the source of infection portends a poor outcome.
• Survival:
  • Sepsis: Hospital mortality rates typically range from 10-30%.
  • Septic Shock: Hospital mortality rates are significantly higher, ranging from 30-50%.
  • Long-term Mortality: Patients surviving sepsis have a significantly higher long-term mortality rate compared to age-matched controls, often due to chronic organ dysfunction and increased vulnerability to subsequent infections.
• Quality of Life:
  • Many sepsis survivors experience a diminished quality of life due to persistent physical, cognitive, and psychological impairments (Post-Sepsis Syndrome).
  • Rates of return to previous employment and functional independence are often low, particularly for those with severe sepsis or septic shock.

Prevention

Prevention of sepsis involves strategies across primary, secondary, and tertiary levels.

• Primary (Preventing Initial Occurrence):
  • Vaccination: Promote and ensure high rates of vaccination against common infectious diseases (e.g., influenza, pneumococcal, meningococcal, tetanus, diphtheria, pertussis).
  • Infection Prevention and Control: Strict adherence to hand hygiene, appropriate use of personal protective equipment, environmental cleaning, and sterile techniques for invasive procedures.
  • Antimicrobial Stewardship: Prudent use of antibiotics to prevent antimicrobial resistance and C. difficile infections.
  • Management of Chronic Diseases: Optimize control of diabetes, heart failure, kidney disease, etc., to reduce infection risk.
  • Good Nutrition and Lifestyle: Support overall immune health.
• Secondary (Early Detection and Intervention):
  • Sepsis Screening Tools: Implement validated screening tools (e.g., qSOFA, NEWS2, MEWS) in emergency departments and hospital wards to identify at-risk patients rapidly.
  • Rapid Response Teams (RRTs)/Medical Emergency Teams (METs): Activation of RRTs for patients meeting early warning scores or clinical deterioration to facilitate early intervention.
  • Education: Train healthcare professionals and the public about sepsis signs and symptoms.
  • Electronic Health Record (EHR) Alerts: Develop alerts to notify clinicians of potential sepsis cases.
• Tertiary (Preventing Complications/Recurrence):
  • Early Mobilization and Rehabilitation: In the ICU and post-discharge to mitigate physical deconditioning.
  • Psychological Support: Screening for and management of anxiety, depression, and PTSD post-sepsis.
  • Patient and Family Education: About post-sepsis syndrome and follow-up care.
  • Follow-up Clinics: Specialized post-ICU or sepsis clinics to provide comprehensive, multidisciplinary care.
  • Optimization of Chronic Conditions: Continued management of comorbidities to prevent future infections.

Special Populations

Sepsis presentation and management require specific considerations in certain patient groups.

• Pediatric:
  • Definition: Sepsis in children includes suspected infection plus $\ge$ 2 systemic inflammatory response syndrome (SIRS) criteria (one of which must be abnormal temperature or leukocyte count). Septic shock includes sepsis with cardiovascular dysfunction (hypotension or signs of poor perfusion, even with normal BP).
  • Presentation: Often atypical. Neonates/infants may present with hypothermia, lethargy, poor feeding, decreased activity, or subtle color changes (mottling). Older children may have fever, irritability, or tachycardia. Hypotension is a late and ominous sign in children.
  • Fluid Resuscitation: Administer isotonic crystalloids in boluses of 10-20 mL/kg over 5-10 minutes, reassessing after each bolus. Total fluid volumes are typically less than in adults to avoid fluid overload.
  • Vasopressors: Epinephrine or norepinephrine are often first-line agents in pediatric septic shock.
  • Adrenal Insufficiency: More common in pediatric septic shock, consider hydrocortisone.
  • Age-Specific Vital Signs: Use age-appropriate vital sign ranges.
• Geriatric:
  • Presentation: Often vague and atypical. May present with confusion, generalized weakness, falls, or functional decline without significant fever or leukocytosis. Hypothermia is common.
  • Comorbidities: High prevalence of chronic diseases (cardiac, renal, pulmonary) and polypharmacy, which complicate management and increase susceptibility to side effects.
  • Fluid Management: Increased risk of fluid overload, requiring careful monitoring and potentially lower volumes.
  • Cognitive Reserve: Reduced cognitive reserve makes them more vulnerable to delirium.
  • Higher Mortality: Geriatric patients have significantly higher morbidity and mortality from sepsis.
• Pregnancy:
  • Physiological Changes: Pregnancy involves physiologic hypervolemia, increased cardiac output, and a relative immunosuppression, which can mask early signs of sepsis and alter responses to therapy.
  • Common Sources: Puerperal infection (endometritis, chorioamnionitis), pyelonephritis, pneumonia, appendicitis.
  • Fetal Considerations: Maternal sepsis poses a direct threat to the fetus (e.g., preterm labor, fetal distress, intrauterine demise). Management aims to stabilize the mother first, while monitoring fetal well-being.
  • Antibiotic Choice: Consider fetal safety when selecting antibiotics.
  • Delivery: Decision regarding timing and mode of delivery in cases of severe maternal sepsis requires multidisciplinary discussion.
• Comorbidities:
  • Chronic Kidney Disease (CKD): Careful fluid management to avoid overload; potential need for earlier RRT. Altered drug clearance.
  • Heart Failure: Increased risk of fluid overload with aggressive resuscitation. Requires careful monitoring of cardiac function.
  • Diabetes Mellitus: Poor glycemic control increases infection risk. Requires strict glycemic management in sepsis.
  • Immunosuppression: Blunted inflammatory response, requiring higher index of suspicion. May need prolonged or broader spectrum antibiotics.

Clinical Pearls

• Diagnostic:
  • Think Sepsis Early: Any patient with suspected infection and new organ dysfunction should be evaluated for sepsis. Use validated screening tools (qSOFA) at the bedside.
  • Lactate is Key: Initial and serial lactate levels are crucial for identifying hypoperfusion and monitoring response to resuscitation.
  • Cultures Before Antibiotics: Prioritize obtaining blood cultures, but do not delay antibiotics for culture collection if it causes significant delay (>45 minutes).
  • Source Control is Paramount: Identifying and controlling the source of infection (e.g., draining an abscess, removing an infected device) is as important as antibiotics and fluid resuscitation.
• Treatment:
  • Time is Tissue: Implement the "Hour-1 Bundle" rapidly. Delays significantly increase mortality.
  • Fluid Responsiveness: Not all hypotensive patients are fluid responsive. Use dynamic measures (e.g., passive leg raise) to guide fluid administration, especially after initial bolus. Avoid excessive fluid administration.
  • Norepinephrine First: Norepinephrine is the first-choice vasopressor for septic shock.
  • Antibiotic De-escalation: Once culture results are available, narrow the antibiotic spectrum to prevent resistance and adverse effects. Consider procalcitonin for guiding discontinuation.
  • Comprehensive Supportive Care: Ventilator management, glycemic control, DVT/stress ulcer prophylaxis, and early mobilization are vital components of care.
• Pitfalls:
  • Delayed Diagnosis: Missing subtle signs in early sepsis or in special populations (elderly, immunocompromised).
  • Delayed Antibiotics: Every hour of delay increases mortality.
  • Inadequate Fluid Resuscitation: Under-resuscitation can lead to persistent hypoperfusion.
  • Excessive Fluid Resuscitation: Can lead to pulmonary edema, abdominal compartment syndrome, and worsen outcomes.
  • Failure of Source Control: If the source of infection is not eradicated, sepsis will likely persist or recur.
  • Inappropriate Antibiotic Choice: Not covering likely pathogens or not narrowing spectrum when possible.
  • Underestimation of Post-Sepsis Syndrome: Failing to address the long-term physical, cognitive, and psychological sequelae.

Recent Updates

• Guidelines: The 2021 Surviving Sepsis Campaign (SSC) International Guidelines for the Management of Sepsis and Septic Shock are the most current comprehensive recommendations. Key changes include:
  • Stronger emphasis on the "Hour-1 Bundle" of care.
  • Recommendation for balanced crystalloids over normal saline for fluid resuscitation.
  • Recommendation against routine use of vitamin C, thiamine, and hydrocortisone combination therapy outside of clinical trials.
  • Emphasis on early administration of broad-spectrum antibiotics, with guidance on duration.
  • Revised recommendations for vasopressor initiation and escalation.
• Evidence: Ongoing research continues to refine sepsis management:
  • Fluid Choice: Multiple large trials (e.g., SMART, SALT-ED, SPLIT, PLUS) reinforce the safety and potential benefits of balanced crystalloids over normal saline.
  • Vasopressor Timing: Studies increasingly support early initiation of vasopressors in septic shock to prevent prolonged hypotension, potentially improving outcomes.
  • Biomarkers: Research into novel biomarkers for early detection, prognosis, and antibiotic stewardship (e.g., transcriptomics, metabolomics) is ongoing, but procalcitonin remains the most widely used for de-escalation.
  • Post-Sepsis Syndrome: Growing recognition of the significant long-term burden, leading to increased research in rehabilitation strategies and follow-up care.
• Controversies:
  • Vitamin C, Thiamine, and Hydrocortisone Cocktail: While some small studies showed promising results, larger, well-designed trials (e.g., VITAMINS, ACTS, OVATION) have generally not supported a benefit for this combination in improving mortality, leading to a strong recommendation against its routine use in the SSC 2021 guidelines.
  • Optimal Fluid Strategy: While balanced crystalloids are preferred, the optimal total fluid volume and timing of fluid cessation remain debated.
  • Role of Adjunctive Therapies: Therapies like polymyxin B hemoperfusion, albumin, or specific immunomodulatory agents lack strong evidence for routine use.

Key References

• Guidelines:
  • Evans, L., Rhodes, A., Alhazzani, W., et al. (2021). Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Medicine, 47(11), 1181-1247.
  • Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.
• Studies:
  • Seymour, C. W., et al. (2017). Time to Treatment and Mortality During Sepsis and Septic Shock. New England Journal of Medicine, 376(23), 2235-2244. (Emphasizes importance of timely intervention)
  • Brown, S. M., et al. (2018). Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis: A Systematic Review and Meta-Analysis. Annals of Internal Medicine, 169(12), 856-865. (Meta-analysis on VITAMINS cocktail)
  • Self, W. H., et al. (2020). Effect of Vitamin C, Hydrocortisone, and Thiamine on Organ Dysfunction in Sepsis: The VITAMINS Randomized Clinical Trial. JAMA, 324(22), 2316-2326. (Large trial on VITAMINS cocktail, no significant benefit)
  • Semler, M. W., et al. (2018). Balanced Crystalloids versus Saline in Critically Ill Adults. New England Journal of Medicine, 378(20), 1964-1972. (SMART trial, supporting balanced crystalloids)
• Reviews:
  • Hotchkiss, R. S., et al. (2016). Sepsis and septic shock. Nature Reviews Disease Primers, 2, 16045. (Comprehensive review of pathophysiology and management)
  • Prescott, H. C., & Angus, D. C. (2018). Enhancing Recovery From Sepsis: A Review. JAMA, 319(7), 698-705. (Focus on post-sepsis syndrome and recovery)